The attempts to oral delivery of lipids can be challenging. Self-emulsifying drug delivery system (SEDDS) plays a vital role to tackle this problem. SEDDS is composed of an oil phase, surfactants, co-surfactants, emulsifying agents, and co-solvents. SEDDS can be categorized into self-nano-emulsifying agents (SNEDDS) and self-micro-emulsifying agents (SMEDDS). The characterization of SEDDS includes size, zeta potential analysis, and surface morphology via electron microscopy and phase separation methods. SEDDS can be well characterized through different techniques for size and morphology. Supersaturation is the phenomenon applied in case of SEDDS, in which polymers and copolymers are used for SEDDS preparation. A supersaturated SEDDS formulation kinetically and thermodynamically inhibits the precipitation of drug molecules by retarding nucleation and crystal growth in the aqueous medium. Self-emulsification approach has been successful in the delivery of anti-cancer agents, anti-viral drugs, anti-bacterial, immunosuppressant, and natural products such as antioxidants as well as alkaloids. At present, more than four SEDDS drug products are available in the market. SEDDS have tremendous capabilities which are yet to be explored which would be beneficial in oral lipid delivery.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Mahmooda A, Bernkop-Schnurch AM. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Del Rev. 2018. https://doi.org/10.1016/j.addr.2018.07.001.
Viswanathan P, Muralidaran Y, Ragavan G. Challenges in oral drug delivery: a nano-based strategy to overcome nanostructures for oral medicine in EA Grumezescu. Nanostruct Oral Med. 2017:173–20.
Gupta H, Bhandari D, Sharma. A recent trends in oral drug delivery: a review. Recent Pat Drug Deliv Formul. 2009;3:162–73.
Verma P, Thakur AS, Deshmukh K, Jha AK, Verma S. Routes of drug administration. Int J Pharm Res. 2010;1:54–9.
Feeney OM, Crum MF, McEvoy CL, Trevaskis NL, Pouton CW, Charman WN, et al. 50 years of oral lipid-based formulations: provenance, progress and future perspectives. Adv Drug Del Rev. 2016;101:167–94.
Kalepun S, Manthina M, Padavala V. Oral lipid-based drug delivery systems: an overview. Acta Pharm Sin B. 2013;3:361–72.
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.
Karan M, Rajashree CM, Arti RT. Challenges in oral delivery: role of P-gp efflux pump. Curr Drug Ther. 2014;9:47–55.
Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev. 1997;25:47–58.
Kosnik AC, Szekalska M, Amelian A, Szymanska E. Development and evaluation of liquid and solid self-emulsifying drug delivery system for atorvastatin. Molecules. 2015;20:21010–22.
Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87–93.
Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurement and particle size analysis. Int J Pharm. 1993;96:147–55.
Mahapatra AK, Murthy PN. Self-emulsifying drug delivery systems (SEDDS): an update from formulation development to therapeutic strategies. Int J Pharm Tech Res. 2014;6:545–68.
Sebastain G, Rajasree PH, George J, Gowda DV. Self-micron emulsifying drug delivery systems (SMEEDS) as a potential drug delivery system-novel applications and future perspectives: a review. Int J Pharm. 2016;6:105–10.
Patel SN, Patel DN, Patel TD, Prajapati TH, Parikh BN. Self-emulsifying drug delivery system. J Glob Pharm Tech. 2010;2:29–37.
Xu X, Cao M, Ren L, Qian Y, Chen G. Preparation and optimization of rivaroxaban by self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability and no food effect. AAPS PharmSciTech. 2018;19:1847–59.
Khedekar K, Mittal S. Self-emulsifying drug delivery system: a review. Int J Pharm Sci Res. 2013;4:4494–507.
Fotouh KA, Allam AA, El-Badry M, El-Sayed AM. Self-emulsifying drug-delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects. Nanomedicine. 2018;13. https://doi.org/10.2217/nnm-2017-0354.
Lavra ZMM, Santana DPD, Re M.I. Solubility and dissolution performances of spray dried solid dispersion of efavirenz in soluplus. Drug Dev Ind Pharm 2017;43: 42–54.
Ikasari ED, Fudholi A, Martono S, Marchaban. Investigation of nifedipine solid dispersion with solvent PVP K-30. Int J Pharm Pharm Sci. 2015;7:389–92.
Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of poorly water-soluble LTB4 inhibitor. J Pharm Sci. 1998;87:164–9.
Pillay V, Fassihi R. Unconventional dissolution methodologies. J Pharm Sci. 1999;88:843–51.
Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci. 2000;2:S93–8.
Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, et al. Relationship between the molecular structures and emulsification properties of edible oils. Biosci Biotechnol Biochem. 1994;58:1258–61.
Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm Dev Technol. 1996;1:147–57.
Reiss H. Entropy-induced dispersion of bulk liquids. J Colloid Interface Sci. 1975;53:61–70.
Boltri L, Canal T, Esposito PA, Carli F. Lipid nanoparticles: evaluation of some critical formulation parameters. Proc Intern Symp Control Rel Bioact Mater. 1993;20:346–7.
Xu R. Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology. 2008;6:112–5.
Pecora R. Dynamic light scattering measurement of nanometer particles in liquids. J Nanopart Res. 2009;2:123–31.
Goddeeris C, Goderis B, van den Mooter G. Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release. Eur J Pharm Sci. 2010;40:110–7.
Gradzielski M. Recent developments in the characterization of microemulsions. Curr Opin Cold Int Sci. 2008;13:263–9.
Vogt FG. Solid-state characterization of amorphous dispersions. In: Newman A, editor. Amorph solid dispersions: Pharm; 2015. p. 117–78.
Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nano-emulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380:133–41.
Kataoka M, Sugano K, da Costa Mathews C. Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development. Pharm Res. 2012;29:1485–94.
Simonelli AP, Mehta SC, Higuchi WI. Inhibition of sulfathiazole crystal growth by polyvinyl pyrrolidone. J Pharm Sci. 1970;59:633–8.
Sekikawa H, Fujiwara J, Naganuma T, Nakano M, Arita T. Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinyl pyrrolidone coprecipitate. Chem Pharm Bull. 1978;26:3033–9.
O’Driscoll KM, Corrigan OI. Chlorothiazidepolyvinyl pyrrolidone (PVP) interactions: influence on membrane permeation (everted rat intestine) and dissolution. Drug Dev and Ind Pharm. 1982;8:547–64.
Megrab NA, Williams AC, Barry BW. Oestradiol permeation through human skin silastic membrane: effects of propylene glycol and supersaturation. J Control Release. 1995;36:277–94.
Ma X, Taw J, Chiang C. Control of drug crystallization in transdermal matrix system. Int J Pharm. 1996;142:115–9.
Schwarb FP, Imanidis G, Smith EW, Haigh JM, Surber C. Effect of concentration and degree of saturation of topical fluocinonide formulations availability on human skin. Pharm Res. 1997;16:909–15.
Raghavan SL, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm. 2001a;212:213–21.
Raghavan RL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm. 2001b;221:95–105.
Quan G, Niu B, Singh V, Zhou Y, Wu CY, Pan X, et al. Supersaturable solid self-micro emulsifying drug delivery system: precipitation inhibition and bioavailability enhancement. Int J Nanomed. 2017;12:8801–11.
Gao P, Guyton ME, Huang T, Bauer J, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water-soluble drug pnu-91325 by super saturatable formulations. Drug Dev Ind Pharm. 2004;30:221–9.
Higuchi T. Physical chemical analysis of percutaneous absorption process. J Soc Cosmet Chem. 1960;11:85–97.
Halliwel B, Gutteridge JMC. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med. 1995;18:125–6.
Li F, Hu R, Wang B, Gui Y, Cheng G, Gao S, et al. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 2017;7(3):353–60.
Charman WN, Stella VJ. Estimating the maximal potentials for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm. 1986;34:175–8.
Jain S, Jain AK, Pohekar M, Kaushik T. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications on drug induced cardiotoxicity and nephrotoxicity. Free Radic Biol Med. 2013;65:117–30.
Mamadou GC, Charrueau JD, Nzouzi NL, Eto B, Ponchel G. Increased intestinal permeation and modulation of pre-systemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems. Int J Pharm. 2017;521:150–5.
Andey T, Patel A, Marepally S, Chougule M, Spencer SD, Rishi AK, et al. Formulation, pharmacokinetic, and efficacy studies of mannosylated self-emulsifying solid dispersions of noscapine. PLoS One. 2016;11:e0146804.
Seo YG, Kima DH, Ramasamy T, Kim JH, Marasini N, Oh YK, et al. Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm. 2013;452:412–20.
Wang YJ, Sun J, Zhang T, Liu H, He F, He Z. Enhanced oral bioavailability of tacrolimus in rats by self-micro emulsifying drug delivery systems. Drug Dev and Ind Pharm. 2011;37:1225–30.
Patela AR, Doddapanenia R, Andeya T, Wilson H, Safeb S, Singh M. Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity. J Control Release. 2015;10:18–26.
Wang Y, Yu N, Guo R, Yang M, Shan L, Huang W, et al. Enhancing in vivo bioavailability in beagle dogs of GLM-7 as a novel anti-leukemia drug through a self-emulsifying drug delivery system for oral delivery. Curr Drug Deliv. 2016;13:131–42.
Gurav NP, Dandagi MP, Gadad AP, Masthiholimath VS. Solubility enhancement of satranidazole using self-emulsified drug delivery systems. Ind J Pharm Educ Res. 2015;50:3.
Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, et al. Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharm. 2009;372:76–84.
Cohen SJW, Schuurman R, Burger DM, Koopmans PP, Sprenger HG, Juttman JR, et al. Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study). JAIDS. 1999;13:53–8.
Buss N, Snell P, Bock J, Hsu A, Jorga K. Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration. Br J Clin Pharmacol. 2001;52:255–64.
Jing B, Wang Z, Yang R, Zheng X, Zhao X, Tang S, and He Z. Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets. Drug Dev Ind Pharm. 2016;42:506–12.
Bakhle SS, Avari JG. Development and characterization of solid self-emulsifying drug delivery system of cilnidipine. Chem Pharm Bull. 2015;63:408–17.
Boxin OU, Dejian H, Maureen AF, Elizabeth KD. Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. J Agric Food Chem. 2002;5:223–8.
Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine. 2010;5:1595–616.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disov. 2006;5:493–506.
Chen Y, Zhang H, Yang J, Sun H. Improved antioxidant capacity of optimization of a self-microemulsifying drug delivery system for resveratrol. Molecules. 2015;20:21167–77.
Li W, Shao Y, Hu L. BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles. Cancer Biol Ther. 2007;6:787–94.
Liu Z, Liu D, Wang L, Zhang J, Zhang N. Docetaxel-loaded pluronic P123 polymeric micelles: in vitro and in vivo evaluation. Int J Mol Sci. 2011;12:1684–96.
Sun S. Acrylamide derivative and use thereof in manufacture of medicament. 2010; Patent, US2012/0116075A1.
Sun S. Acrylamide derivative and use thereof in manufacture of medicament. 2010; Patent, CN102421754B.
Yeni P. Tipranavir: a protease inhibitor from a new class with distinct antiviral activity. JAIDS. 2003;34:S91–4.
Meng J, Li S, Yao Q, Zhang L, Weng Y, Cai C, et al. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. Drug Dev Ind Pharm. 2014;40:929–36.
Karavas E, Ktistis G, Xenakis A, Georgarakis E. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinyl pyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm. 2005;31:473–89.
Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporin in rats through the reduction of emulsion droplet size. Pharm Res. 1989;6:40–3.
Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–72.
Kauss T, Gaubert A, Tabaran L, Tonelli G, Phoeung T, Langlois MH, et al. Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drug. Int J Pharm. 2018;536:283–91.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Guest Editor: Sanyog Jain
About this article
Cite this article
Rani, S., Rana, R., Saraogi, G.K. et al. Self-Emulsifying Oral Lipid Drug Delivery Systems: Advances and Challenges. AAPS PharmSciTech 20, 129 (2019). https://doi.org/10.1208/s12249-019-1335-x
- lipid delivery